The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Hepatitis Rapid Testing Market Research Report 2025
Synopsis
Rapid diagnostics test are making their way in the field of hepatitis rapid testing, as these allow for diagnosing acute infections and confirming chronic cases of hepatitis allowing prompt action to be taken for treatment of the infected cases.
The global Hepatitis Rapid Testing market was valued at US$ 2863 million in 2023 and is anticipated to reach US$ 5086.4 million by 2030, witnessing a CAGR of 8.4% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Hepatitis Rapid Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis Rapid Testing.
Report Scope
The Hepatitis Rapid Testing market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hepatitis Rapid Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hepatitis Rapid Testing manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Standard Diagnostics
DiaSorin
SD Biosensor
Kehua-Bio-Engineering
bioMerieux
Biokit S.A.
RPC Diagnostics System
Dia Pro- Diagnostic Bioprobes
Creative Diagnostics
Asan Pharm
Fujirebio
Orasure Technologies
InTec Products
Bio-Rad Laboratories
Sysmex Asia Pacific
Roche
Segment by Type
Test Strip
Cassette
Segment by Application
Diagnostic Centers
Pathology Laboratories
Specialty Clinics
Hospitals
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hepatitis Rapid Testing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hepatitis Rapid Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Rapid diagnostics test are making their way in the field of hepatitis rapid testing, as these allow for diagnosing acute infections and confirming chronic cases of hepatitis allowing prompt action to be taken for treatment of the infected cases.
The global Hepatitis Rapid Testing market was valued at US$ 2863 million in 2023 and is anticipated to reach US$ 5086.4 million by 2030, witnessing a CAGR of 8.4% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Hepatitis Rapid Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis Rapid Testing.
Report Scope
The Hepatitis Rapid Testing market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hepatitis Rapid Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hepatitis Rapid Testing manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Standard Diagnostics
DiaSorin
SD Biosensor
Kehua-Bio-Engineering
bioMerieux
Biokit S.A.
RPC Diagnostics System
Dia Pro- Diagnostic Bioprobes
Creative Diagnostics
Asan Pharm
Fujirebio
Orasure Technologies
InTec Products
Bio-Rad Laboratories
Sysmex Asia Pacific
Roche
Segment by Type
Test Strip
Cassette
Segment by Application
Diagnostic Centers
Pathology Laboratories
Specialty Clinics
Hospitals
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hepatitis Rapid Testing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hepatitis Rapid Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Hepatitis Rapid Testing Market Overview
1.1 Product Overview and Scope of Hepatitis Rapid Testing
1.2 Hepatitis Rapid Testing Segment by Type
1.2.1 Global Hepatitis Rapid Testing Market Value Comparison by Type (2024-2030)
1.2.2 Test Strip
1.2.3 Cassette
1.3 Hepatitis Rapid Testing Segment by Application
1.3.1 Global Hepatitis Rapid Testing Market Value by Application: (2024-2030)
1.3.2 Diagnostic Centers
1.3.3 Pathology Laboratories
1.3.4 Specialty Clinics
1.3.5 Hospitals
1.3.6 Others
1.4 Global Hepatitis Rapid Testing Market Size Estimates and Forecasts
1.4.1 Global Hepatitis Rapid Testing Revenue 2019-2030
1.4.2 Global Hepatitis Rapid Testing Sales 2019-2030
1.4.3 Global Hepatitis Rapid Testing Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Hepatitis Rapid Testing Market Competition by Manufacturers
2.1 Global Hepatitis Rapid Testing Sales Market Share by Manufacturers (2019-2024)
2.2 Global Hepatitis Rapid Testing Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Hepatitis Rapid Testing Average Price by Manufacturers (2019-2024)
2.4 Global Hepatitis Rapid Testing Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hepatitis Rapid Testing, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hepatitis Rapid Testing, Product Type & Application
2.7 Hepatitis Rapid Testing Market Competitive Situation and Trends
2.7.1 Hepatitis Rapid Testing Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hepatitis Rapid Testing Players Market Share by Revenue
2.7.3 Global Hepatitis Rapid Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hepatitis Rapid Testing Retrospective Market Scenario by Region
3.1 Global Hepatitis Rapid Testing Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Hepatitis Rapid Testing Global Hepatitis Rapid Testing Sales by Region: 2019-2030
3.2.1 Global Hepatitis Rapid Testing Sales by Region: 2019-2024
3.2.2 Global Hepatitis Rapid Testing Sales by Region: 2025-2030
3.3 Global Hepatitis Rapid Testing Global Hepatitis Rapid Testing Revenue by Region: 2019-2030
3.3.1 Global Hepatitis Rapid Testing Revenue by Region: 2019-2024
3.3.2 Global Hepatitis Rapid Testing Revenue by Region: 2025-2030
3.4 North America Hepatitis Rapid Testing Market Facts & Figures by Country
3.4.1 North America Hepatitis Rapid Testing Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Hepatitis Rapid Testing Sales by Country (2019-2030)
3.4.3 North America Hepatitis Rapid Testing Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Hepatitis Rapid Testing Market Facts & Figures by Country
3.5.1 Europe Hepatitis Rapid Testing Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Hepatitis Rapid Testing Sales by Country (2019-2030)
3.5.3 Europe Hepatitis Rapid Testing Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hepatitis Rapid Testing Market Facts & Figures by Country
3.6.1 Asia Pacific Hepatitis Rapid Testing Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Hepatitis Rapid Testing Sales by Country (2019-2030)
3.6.3 Asia Pacific Hepatitis Rapid Testing Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Hepatitis Rapid Testing Market Facts & Figures by Country
3.7.1 Latin America Hepatitis Rapid Testing Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Hepatitis Rapid Testing Sales by Country (2019-2030)
3.7.3 Latin America Hepatitis Rapid Testing Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hepatitis Rapid Testing Market Facts & Figures by Country
3.8.1 Middle East and Africa Hepatitis Rapid Testing Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Hepatitis Rapid Testing Sales by Country (2019-2030)
3.8.3 Middle East and Africa Hepatitis Rapid Testing Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hepatitis Rapid Testing Sales by Type (2019-2030)
4.1.1 Global Hepatitis Rapid Testing Sales by Type (2019-2024)
4.1.2 Global Hepatitis Rapid Testing Sales by Type (2025-2030)
4.1.3 Global Hepatitis Rapid Testing Sales Market Share by Type (2019-2030)
4.2 Global Hepatitis Rapid Testing Revenue by Type (2019-2030)
4.2.1 Global Hepatitis Rapid Testing Revenue by Type (2019-2024)
4.2.2 Global Hepatitis Rapid Testing Revenue by Type (2025-2030)
4.2.3 Global Hepatitis Rapid Testing Revenue Market Share by Type (2019-2030)
4.3 Global Hepatitis Rapid Testing Price by Type (2019-2030)
5 Segment by Application
5.1 Global Hepatitis Rapid Testing Sales by Application (2019-2030)
5.1.1 Global Hepatitis Rapid Testing Sales by Application (2019-2024)
5.1.2 Global Hepatitis Rapid Testing Sales by Application (2025-2030)
5.1.3 Global Hepatitis Rapid Testing Sales Market Share by Application (2019-2030)
5.2 Global Hepatitis Rapid Testing Revenue by Application (2019-2030)
5.2.1 Global Hepatitis Rapid Testing Revenue by Application (2019-2024)
5.2.2 Global Hepatitis Rapid Testing Revenue by Application (2025-2030)
5.2.3 Global Hepatitis Rapid Testing Revenue Market Share by Application (2019-2030)
5.3 Global Hepatitis Rapid Testing Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Hepatitis Rapid Testing Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbott Hepatitis Rapid Testing Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Standard Diagnostics
6.2.1 Standard Diagnostics Corporation Information
6.2.2 Standard Diagnostics Description and Business Overview
6.2.3 Standard Diagnostics Hepatitis Rapid Testing Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Standard Diagnostics Hepatitis Rapid Testing Product Portfolio
6.2.5 Standard Diagnostics Recent Developments/Updates
6.3 DiaSorin
6.3.1 DiaSorin Corporation Information
6.3.2 DiaSorin Description and Business Overview
6.3.3 DiaSorin Hepatitis Rapid Testing Sales, Revenue and Gross Margin (2019-2024)
6.3.4 DiaSorin Hepatitis Rapid Testing Product Portfolio
6.3.5 DiaSorin Recent Developments/Updates
6.4 SD Biosensor
6.4.1 SD Biosensor Corporation Information
6.4.2 SD Biosensor Description and Business Overview
6.4.3 SD Biosensor Hepatitis Rapid Testing Sales, Revenue and Gross Margin (2019-2024)
6.4.4 SD Biosensor Hepatitis Rapid Testing Product Portfolio
6.4.5 SD Biosensor Recent Developments/Updates
6.5 Kehua-Bio-Engineering
6.5.1 Kehua-Bio-Engineering Corporation Information
6.5.2 Kehua-Bio-Engineering Description and Business Overview
6.5.3 Kehua-Bio-Engineering Hepatitis Rapid Testing Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Kehua-Bio-Engineering Hepatitis Rapid Testing Product Portfolio
6.5.5 Kehua-Bio-Engineering Recent Developments/Updates
6.6 bioMerieux
6.6.1 bioMerieux Corporation Information
6.6.2 bioMerieux Description and Business Overview
6.6.3 bioMerieux Hepatitis Rapid Testing Sales, Revenue and Gross Margin (2019-2024)
6.6.4 bioMerieux Hepatitis Rapid Testing Product Portfolio
6.6.5 bioMerieux Recent Developments/Updates
6.7 Biokit S.A.
6.6.1 Biokit S.A. Corporation Information
6.6.2 Biokit S.A. Description and Business Overview
6.6.3 Biokit S.A. Hepatitis Rapid Testing Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Biokit S.A. Hepatitis Rapid Testing Product Portfolio
6.7.5 Biokit S.A. Recent Developments/Updates
6.8 RPC Diagnostics System
6.8.1 RPC Diagnostics System Corporation Information
6.8.2 RPC Diagnostics System Description and Business Overview
6.8.3 RPC Diagnostics System Hepatitis Rapid Testing Sales, Revenue and Gross Margin (2019-2024)
6.8.4 RPC Diagnostics System Hepatitis Rapid Testing Product Portfolio
6.8.5 RPC Diagnostics System Recent Developments/Updates
6.9 Dia Pro- Diagnostic Bioprobes
6.9.1 Dia Pro- Diagnostic Bioprobes Corporation Information
6.9.2 Dia Pro- Diagnostic Bioprobes Description and Business Overview
6.9.3 Dia Pro- Diagnostic Bioprobes Hepatitis Rapid Testing Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Dia Pro- Diagnostic Bioprobes Hepatitis Rapid Testing Product Portfolio
6.9.5 Dia Pro- Diagnostic Bioprobes Recent Developments/Updates
6.10 Creative Diagnostics
6.10.1 Creative Diagnostics Corporation Information
6.10.2 Creative Diagnostics Description and Business Overview
6.10.3 Creative Diagnostics Hepatitis Rapid Testing Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Creative Diagnostics Hepatitis Rapid Testing Product Portfolio
6.10.5 Creative Diagnostics Recent Developments/Updates
6.11 Asan Pharm
6.11.1 Asan Pharm Corporation Information
6.11.2 Asan Pharm Hepatitis Rapid Testing Description and Business Overview
6.11.3 Asan Pharm Hepatitis Rapid Testing Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Asan Pharm Hepatitis Rapid Testing Product Portfolio
6.11.5 Asan Pharm Recent Developments/Updates
6.12 Fujirebio
6.12.1 Fujirebio Corporation Information
6.12.2 Fujirebio Hepatitis Rapid Testing Description and Business Overview
6.12.3 Fujirebio Hepatitis Rapid Testing Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Fujirebio Hepatitis Rapid Testing Product Portfolio
6.12.5 Fujirebio Recent Developments/Updates
6.13 Orasure Technologies
6.13.1 Orasure Technologies Corporation Information
6.13.2 Orasure Technologies Hepatitis Rapid Testing Description and Business Overview
6.13.3 Orasure Technologies Hepatitis Rapid Testing Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Orasure Technologies Hepatitis Rapid Testing Product Portfolio
6.13.5 Orasure Technologies Recent Developments/Updates
6.14 InTec Products
6.14.1 InTec Products Corporation Information
6.14.2 InTec Products Hepatitis Rapid Testing Description and Business Overview
6.14.3 InTec Products Hepatitis Rapid Testing Sales, Revenue and Gross Margin (2019-2024)
6.14.4 InTec Products Hepatitis Rapid Testing Product Portfolio
6.14.5 InTec Products Recent Developments/Updates
6.15 Bio-Rad Laboratories
6.15.1 Bio-Rad Laboratories Corporation Information
6.15.2 Bio-Rad Laboratories Hepatitis Rapid Testing Description and Business Overview
6.15.3 Bio-Rad Laboratories Hepatitis Rapid Testing Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Bio-Rad Laboratories Hepatitis Rapid Testing Product Portfolio
6.15.5 Bio-Rad Laboratories Recent Developments/Updates
6.16 Sysmex Asia Pacific
6.16.1 Sysmex Asia Pacific Corporation Information
6.16.2 Sysmex Asia Pacific Hepatitis Rapid Testing Description and Business Overview
6.16.3 Sysmex Asia Pacific Hepatitis Rapid Testing Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Sysmex Asia Pacific Hepatitis Rapid Testing Product Portfolio
6.16.5 Sysmex Asia Pacific Recent Developments/Updates
6.17 Roche
6.17.1 Roche Corporation Information
6.17.2 Roche Hepatitis Rapid Testing Description and Business Overview
6.17.3 Roche Hepatitis Rapid Testing Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Roche Hepatitis Rapid Testing Product Portfolio
6.17.5 Roche Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hepatitis Rapid Testing Industry Chain Analysis
7.2 Hepatitis Rapid Testing Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hepatitis Rapid Testing Production Mode & Process
7.4 Hepatitis Rapid Testing Sales and Marketing
7.4.1 Hepatitis Rapid Testing Sales Channels
7.4.2 Hepatitis Rapid Testing Distributors
7.5 Hepatitis Rapid Testing Customers
8 Hepatitis Rapid Testing Market Dynamics
8.1 Hepatitis Rapid Testing Industry Trends
8.2 Hepatitis Rapid Testing Market Drivers
8.3 Hepatitis Rapid Testing Market Challenges
8.4 Hepatitis Rapid Testing Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Hepatitis Rapid Testing Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Hepatitis Rapid Testing Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Hepatitis Rapid Testing Market Competitive Situation by Manufacturers in 2023
Table 4. Global Hepatitis Rapid Testing Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Hepatitis Rapid Testing Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Hepatitis Rapid Testing Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Hepatitis Rapid Testing Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Hepatitis Rapid Testing Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Hepatitis Rapid Testing, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Hepatitis Rapid Testing, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Hepatitis Rapid Testing, Product Type & Application
Table 12. Global Key Manufacturers of Hepatitis Rapid Testing, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Hepatitis Rapid Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis Rapid Testing as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Hepatitis Rapid Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Hepatitis Rapid Testing Sales by Region (2019-2024) & (K Units)
Table 18. Global Hepatitis Rapid Testing Sales Market Share by Region (2019-2024)
Table 19. Global Hepatitis Rapid Testing Sales by Region (2025-2030) & (K Units)
Table 20. Global Hepatitis Rapid Testing Sales Market Share by Region (2025-2030)
Table 21. Global Hepatitis Rapid Testing Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Hepatitis Rapid Testing Revenue Market Share by Region (2019-2024)
Table 23. Global Hepatitis Rapid Testing Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Hepatitis Rapid Testing Revenue Market Share by Region (2025-2030)
Table 25. North America Hepatitis Rapid Testing Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Hepatitis Rapid Testing Sales by Country (2019-2024) & (K Units)
Table 27. North America Hepatitis Rapid Testing Sales by Country (2025-2030) & (K Units)
Table 28. North America Hepatitis Rapid Testing Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Hepatitis Rapid Testing Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Hepatitis Rapid Testing Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Hepatitis Rapid Testing Sales by Country (2019-2024) & (K Units)
Table 32. Europe Hepatitis Rapid Testing Sales by Country (2025-2030) & (K Units)
Table 33. Europe Hepatitis Rapid Testing Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Hepatitis Rapid Testing Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Hepatitis Rapid Testing Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Hepatitis Rapid Testing Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Hepatitis Rapid Testing Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Hepatitis Rapid Testing Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Hepatitis Rapid Testing Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Hepatitis Rapid Testing Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Hepatitis Rapid Testing Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Hepatitis Rapid Testing Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Hepatitis Rapid Testing Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Hepatitis Rapid Testing Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Hepatitis Rapid Testing Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Hepatitis Rapid Testing Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Hepatitis Rapid Testing Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Hepatitis Rapid Testing Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Hepatitis Rapid Testing Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Hepatitis Rapid Testing Sales (K Units) by Type (2019-2024)
Table 51. Global Hepatitis Rapid Testing Sales (K Units) by Type (2025-2030)
Table 52. Global Hepatitis Rapid Testing Sales Market Share by Type (2019-2024)
Table 53. Global Hepatitis Rapid Testing Sales Market Share by Type (2025-2030)
Table 54. Global Hepatitis Rapid Testing Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Hepatitis Rapid Testing Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Hepatitis Rapid Testing Revenue Market Share by Type (2019-2024)
Table 57. Global Hepatitis Rapid Testing Revenue Market Share by Type (2025-2030)
Table 58. Global Hepatitis Rapid Testing Price (US$/Unit) by Type (2019-2024)
Table 59. Global Hepatitis Rapid Testing Price (US$/Unit) by Type (2025-2030)
Table 60. Global Hepatitis Rapid Testing Sales (K Units) by Application (2019-2024)
Table 61. Global Hepatitis Rapid Testing Sales (K Units) by Application (2025-2030)
Table 62. Global Hepatitis Rapid Testing Sales Market Share by Application (2019-2024)
Table 63. Global Hepatitis Rapid Testing Sales Market Share by Application (2025-2030)
Table 64. Global Hepatitis Rapid Testing Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Hepatitis Rapid Testing Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Hepatitis Rapid Testing Revenue Market Share by Application (2019-2024)
Table 67. Global Hepatitis Rapid Testing Revenue Market Share by Application (2025-2030)
Table 68. Global Hepatitis Rapid Testing Price (US$/Unit) by Application (2019-2024)
Table 69. Global Hepatitis Rapid Testing Price (US$/Unit) by Application (2025-2030)
Table 70. Abbott Corporation Information
Table 71. Abbott Description and Business Overview
Table 72. Abbott Hepatitis Rapid Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Abbott Hepatitis Rapid Testing Product
Table 74. Abbott Recent Developments/Updates
Table 75. Standard Diagnostics Corporation Information
Table 76. Standard Diagnostics Description and Business Overview
Table 77. Standard Diagnostics Hepatitis Rapid Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Standard Diagnostics Hepatitis Rapid Testing Product
Table 79. Standard Diagnostics Recent Developments/Updates
Table 80. DiaSorin Corporation Information
Table 81. DiaSorin Description and Business Overview
Table 82. DiaSorin Hepatitis Rapid Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. DiaSorin Hepatitis Rapid Testing Product
Table 84. DiaSorin Recent Developments/Updates
Table 85. SD Biosensor Corporation Information
Table 86. SD Biosensor Description and Business Overview
Table 87. SD Biosensor Hepatitis Rapid Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. SD Biosensor Hepatitis Rapid Testing Product
Table 89. SD Biosensor Recent Developments/Updates
Table 90. Kehua-Bio-Engineering Corporation Information
Table 91. Kehua-Bio-Engineering Description and Business Overview
Table 92. Kehua-Bio-Engineering Hepatitis Rapid Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Kehua-Bio-Engineering Hepatitis Rapid Testing Product
Table 94. Kehua-Bio-Engineering Recent Developments/Updates
Table 95. bioMerieux Corporation Information
Table 96. bioMerieux Description and Business Overview
Table 97. bioMerieux Hepatitis Rapid Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. bioMerieux Hepatitis Rapid Testing Product
Table 99. bioMerieux Recent Developments/Updates
Table 100. Biokit S.A. Corporation Information
Table 101. Biokit S.A. Description and Business Overview
Table 102. Biokit S.A. Hepatitis Rapid Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Biokit S.A. Hepatitis Rapid Testing Product
Table 104. Biokit S.A. Recent Developments/Updates
Table 105. RPC Diagnostics System Corporation Information
Table 106. RPC Diagnostics System Description and Business Overview
Table 107. RPC Diagnostics System Hepatitis Rapid Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. RPC Diagnostics System Hepatitis Rapid Testing Product
Table 109. RPC Diagnostics System Recent Developments/Updates
Table 110. Dia Pro- Diagnostic Bioprobes Corporation Information
Table 111. Dia Pro- Diagnostic Bioprobes Description and Business Overview
Table 112. Dia Pro- Diagnostic Bioprobes Hepatitis Rapid Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Dia Pro- Diagnostic Bioprobes Hepatitis Rapid Testing Product
Table 114. Dia Pro- Diagnostic Bioprobes Recent Developments/Updates
Table 115. Creative Diagnostics Corporation Information
Table 116. Creative Diagnostics Description and Business Overview
Table 117. Creative Diagnostics Hepatitis Rapid Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Creative Diagnostics Hepatitis Rapid Testing Product
Table 119. Creative Diagnostics Recent Developments/Updates
Table 120. Asan Pharm Corporation Information
Table 121. Asan Pharm Description and Business Overview
Table 122. Asan Pharm Hepatitis Rapid Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Asan Pharm Hepatitis Rapid Testing Product
Table 124. Asan Pharm Recent Developments/Updates
Table 125. Fujirebio Corporation Information
Table 126. Fujirebio Description and Business Overview
Table 127. Fujirebio Hepatitis Rapid Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Fujirebio Hepatitis Rapid Testing Product
Table 129. Fujirebio Recent Developments/Updates
Table 130. Orasure Technologies Corporation Information
Table 131. Orasure Technologies Description and Business Overview
Table 132. Orasure Technologies Hepatitis Rapid Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Orasure Technologies Hepatitis Rapid Testing Product
Table 134. Orasure Technologies Recent Developments/Updates
Table 135. InTec Products Corporation Information
Table 136. InTec Products Description and Business Overview
Table 137. InTec Products Hepatitis Rapid Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. InTec Products Hepatitis Rapid Testing Product
Table 139. InTec Products Recent Developments/Updates
Table 140. Bio-Rad Laboratories Corporation Information
Table 141. Bio-Rad Laboratories Description and Business Overview
Table 142. Bio-Rad Laboratories Hepatitis Rapid Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Bio-Rad Laboratories Hepatitis Rapid Testing Product
Table 144. Bio-Rad Laboratories Recent Developments/Updates
Table 145. Sysmex Asia Pacific Corporation Information
Table 146. Sysmex Asia Pacific Description and Business Overview
Table 147. Sysmex Asia Pacific Hepatitis Rapid Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Sysmex Asia Pacific Hepatitis Rapid Testing Product
Table 149. Sysmex Asia Pacific Recent Developments/Updates
Table 150. Roche Corporation Information
Table 151. Roche Description and Business Overview
Table 152. Roche Hepatitis Rapid Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Roche Hepatitis Rapid Testing Product
Table 154. Roche Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Hepatitis Rapid Testing Distributors List
Table 158. Hepatitis Rapid Testing Customers List
Table 159. Hepatitis Rapid Testing Market Trends
Table 160. Hepatitis Rapid Testing Market Drivers
Table 161. Hepatitis Rapid Testing Market Challenges
Table 162. Hepatitis Rapid Testing Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Hepatitis Rapid Testing
Figure 2. Global Hepatitis Rapid Testing Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Hepatitis Rapid Testing Market Share by Type in 2023 & 2030
Figure 4. Test Strip Product Picture
Figure 5. Cassette Product Picture
Figure 6. Global Hepatitis Rapid Testing Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Hepatitis Rapid Testing Market Share by Application in 2023 & 2030
Figure 8. Diagnostic Centers
Figure 9. Pathology Laboratories
Figure 10. Specialty Clinics
Figure 11. Hospitals
Figure 12. Others
Figure 13. Global Hepatitis Rapid Testing Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Hepatitis Rapid Testing Market Size (2019-2030) & (US$ Million)
Figure 15. Global Hepatitis Rapid Testing Sales (2019-2030) & (K Units)
Figure 16. Global Hepatitis Rapid Testing Average Price (US$/Unit) & (2019-2030)
Figure 17. Hepatitis Rapid Testing Report Years Considered
Figure 18. Hepatitis Rapid Testing Sales Share by Manufacturers in 2023
Figure 19. Global Hepatitis Rapid Testing Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Hepatitis Rapid Testing Players: Market Share by Revenue in 2023
Figure 21. Hepatitis Rapid Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Hepatitis Rapid Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Hepatitis Rapid Testing Sales Market Share by Country (2019-2030)
Figure 24. North America Hepatitis Rapid Testing Revenue Market Share by Country (2019-2030)
Figure 25. United States Hepatitis Rapid Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Hepatitis Rapid Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Hepatitis Rapid Testing Sales Market Share by Country (2019-2030)
Figure 28. Europe Hepatitis Rapid Testing Revenue Market Share by Country (2019-2030)
Figure 29. Germany Hepatitis Rapid Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Hepatitis Rapid Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Hepatitis Rapid Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Hepatitis Rapid Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Hepatitis Rapid Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Hepatitis Rapid Testing Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Hepatitis Rapid Testing Revenue Market Share by Region (2019-2030)
Figure 36. China Hepatitis Rapid Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Hepatitis Rapid Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Hepatitis Rapid Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Hepatitis Rapid Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Hepatitis Rapid Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Hepatitis Rapid Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Hepatitis Rapid Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Hepatitis Rapid Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Hepatitis Rapid Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Hepatitis Rapid Testing Sales Market Share by Country (2019-2030)
Figure 46. Latin America Hepatitis Rapid Testing Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Hepatitis Rapid Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Hepatitis Rapid Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Hepatitis Rapid Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Hepatitis Rapid Testing Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Hepatitis Rapid Testing Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Hepatitis Rapid Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Hepatitis Rapid Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Hepatitis Rapid Testing Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Hepatitis Rapid Testing by Type (2019-2030)
Figure 56. Global Revenue Market Share of Hepatitis Rapid Testing by Type (2019-2030)
Figure 57. Global Hepatitis Rapid Testing Price (US$/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Hepatitis Rapid Testing by Application (2019-2030)
Figure 59. Global Revenue Market Share of Hepatitis Rapid Testing by Application (2019-2030)
Figure 60. Global Hepatitis Rapid Testing Price (US$/Unit) by Application (2019-2030)
Figure 61. Hepatitis Rapid Testing Value Chain
Figure 62. Hepatitis Rapid Testing Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
